vs
Capitol Federal Financial, Inc.（CFFN）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Capitol Federal Financial, Inc.的1.3倍（$75.5M vs $57.7M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 12.1%）
国会联邦储蓄银行（CapFed）成立于1893年，是获得联邦特许并承保的储蓄银行，总部位于堪萨斯州托皮卡。该行目前共有51个网点，覆盖堪萨斯城都会区的堪萨斯州与密苏里州两侧，为个人及企业提供各类金融服务，其控股公司国会联邦金融 Inc.在纳斯达克挂牌上市。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CFFN vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.3倍
$57.7M
两年增速更快
PBYI
近两年复合增速
12.1%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.7M | $75.5M |
| 净利润 | $20.1M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | — | 22.7% |
| 净利率 | 34.9% | — |
| 营收同比 | — | 27.7% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CFFNPBYI
| Q1 26 | $57.7M | — | ||
| Q4 25 | $56.8M | $75.5M | ||
| Q3 25 | $54.6M | $54.5M | ||
| Q2 25 | $50.7M | $52.4M | ||
| Q1 25 | $48.8M | $46.0M | ||
| Q4 24 | $46.9M | $59.1M | ||
| Q3 24 | — | $80.5M | ||
| Q2 24 | $45.0M | $47.1M |
净利润CFFNPBYI
| Q1 26 | $20.1M | — | ||
| Q4 25 | $20.3M | — | ||
| Q3 25 | $18.8M | $8.8M | ||
| Q2 25 | $18.4M | $5.9M | ||
| Q1 25 | $15.4M | $3.0M | ||
| Q4 24 | $15.4M | — | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | $9.6M | $-4.5M |
毛利率CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% |
营业利润率CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 44.4% | 22.7% | ||
| Q3 25 | 42.2% | 17.6% | ||
| Q2 25 | 42.6% | 12.7% | ||
| Q1 25 | 39.5% | 8.7% | ||
| Q4 24 | 40.7% | 22.6% | ||
| Q3 24 | — | 27.4% | ||
| Q2 24 | 34.7% | -4.6% |
净利率CFFNPBYI
| Q1 26 | 34.9% | — | ||
| Q4 25 | 35.7% | — | ||
| Q3 25 | 34.5% | 16.2% | ||
| Q2 25 | 36.2% | 11.2% | ||
| Q1 25 | 31.6% | 6.5% | ||
| Q4 24 | 32.9% | — | ||
| Q3 24 | — | 25.2% | ||
| Q2 24 | 21.4% | -9.6% |
每股收益（稀释后）CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $0.16 | $0.26 | ||
| Q3 25 | $0.14 | $0.17 | ||
| Q2 25 | $0.14 | $0.12 | ||
| Q1 25 | $0.12 | $0.06 | ||
| Q4 24 | $0.12 | $0.40 | ||
| Q3 24 | — | $0.41 | ||
| Q2 24 | $0.07 | $-0.09 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $1.0B | $130.3M |
| 总资产 | $9.8B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CFFNPBYI
| Q1 26 | $2.5M | — | ||
| Q4 25 | $232.6M | $97.5M | ||
| Q3 25 | $252.4M | $94.4M | ||
| Q2 25 | $175.0M | $96.0M | ||
| Q1 25 | $340.4M | $93.2M | ||
| Q4 24 | $170.3M | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $317.8M | $96.8M |
总债务CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M |
股东权益CFFNPBYI
| Q1 26 | $1.0B | — | ||
| Q4 25 | $1.0B | $130.3M | ||
| Q3 25 | $1.0B | $115.3M | ||
| Q2 25 | $1.0B | $104.7M | ||
| Q1 25 | $1.0B | $97.1M | ||
| Q4 24 | $1.0B | $92.1M | ||
| Q3 24 | — | $71.1M | ||
| Q2 24 | $1.0B | $48.5M |
总资产CFFNPBYI
| Q1 26 | $9.8B | — | ||
| Q4 25 | $9.8B | $216.3M | ||
| Q3 25 | $9.8B | $202.9M | ||
| Q2 25 | $9.7B | $194.9M | ||
| Q1 25 | $9.7B | $196.2M | ||
| Q4 24 | $9.5B | $213.3M | ||
| Q3 24 | — | $220.7M | ||
| Q2 24 | $9.6B | $205.0M |
负债/权益比CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $17.4M | $14.4M | ||
| Q3 25 | $55.0M | $9.7M | ||
| Q2 25 | $12.4M | $14.1M | ||
| Q1 25 | $15.5M | $3.6M | ||
| Q4 24 | $5.6M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | $19.1M | $1.0M |
自由现金流CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | $15.8M | $14.4M | ||
| Q3 25 | $49.8M | $9.7M | ||
| Q2 25 | $10.8M | $14.1M | ||
| Q1 25 | $14.7M | $3.6M | ||
| Q4 24 | $4.5M | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | $16.4M | $1.0M |
自由现金流率CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 27.9% | 19.1% | ||
| Q3 25 | 91.3% | 17.7% | ||
| Q2 25 | 21.2% | 26.8% | ||
| Q1 25 | 30.2% | 7.7% | ||
| Q4 24 | 9.5% | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | 36.5% | 2.1% |
资本支出强度CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 2.8% | 0.0% | ||
| Q3 25 | 9.5% | 0.0% | ||
| Q2 25 | 3.2% | 0.0% | ||
| Q1 25 | 1.5% | 0.1% | ||
| Q4 24 | 2.5% | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | 5.9% | 0.0% |
现金转化率CFFNPBYI
| Q1 26 | — | — | ||
| Q4 25 | 0.86× | — | ||
| Q3 25 | 2.93× | 1.10× | ||
| Q2 25 | 0.67× | 2.41× | ||
| Q1 25 | 1.01× | 1.21× | ||
| Q4 24 | 0.36× | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | 1.98× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CFFN
| Net Interest Income | $52.3M | 91% |
| Noninterest Income | $5.5M | 9% |
PBYI
暂无分部数据
